ESR1 and breast carcinoma: Gene set enrichment analysis (GSEA) showed that the “Luminal A Breast Cancer (ERα‐positive breast cancer)” and “Response to tamoxifen or fulvestrant” signatures were enriched in BCs of the W8 group but not of the W10 or W12 groups (Figure 2D,E, Figure S1A,B, Supporting Information).